Biomarkers measured in buccal and blood leukocyte DNA as proxies for colon tissue global methylation

International Journal of Molecular Epidemiology and Genetics

Volumn 5, Issue 2, 2014, Pages 120-124

  Ashbury, Janet E ^a   Taylor, Sherryl A ^b,c   Tse, M Yat ^a   Pang, Stephen C ^a   Louw, Jacob A ^d   Vanner, Stephen J ^a,d   King, Will D ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c ALBERTA HEALTH SERVICES   (Canada)

^d HOTEL DIEU HOSPITAL   (Canada)

Author keywords

Colorectal adenoma; Colorectal cancer; Correlation; Global dna methylation; LINE 1 DNA methylation

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CANCER RISK; CHEEK; COLON; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; CROSS-SECTIONAL STUDY; DNA METHYLATION; FEMALE; GENE; GENE EXPRESSION; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; HUMAN TISSUE; LEUKOCYTE; LONG INTERSPERSED ELEMENT 1 GENE; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; QUESTIONNAIRE; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84901749446     PISSN: 19481756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Goelz SE, Vogelstein B, Hamilton SR, Feinberg AP. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 1985; 228: 187-190.
2. Chalitchagorn K, Shuangshoti S, Hourpai N, Kongruttanachok N, Tangkijvanich P, Thong-ngam D, Voravud N, Sriuranpong V, Mutiran-gura A. Distinctive pattern of LINE-1 methyla-tion level in normal tissues and the association with carcinogenesis. Oncogene 2004; 23: 8841-8846.
3. Suter CM, Martin DI, Ward RL. Hypomethyl-ation of L1 retrotransposons in colorectal cancer and adjacent normal tissue. Int J Colorectal Dis 2004; 19: 95-101.
4. Costello JF, Brena RM. Cancer epigenetics. Edited by Tost J. Epigenetics. Norfolk, UK: Caister Academic Press 2008; pp: 307-310.
5. Cravo M, Fidalgo P, Pereira AD, Gouveia-Olivei-ra A, Chaves P, Selhub J, Mason JB, Mira FC, Leitao CN. DNA methylation as an intermediate biomarker in colorectal cancer: modulation by folic acid supplementation. Eur J Cancer Prev 1994; 3: 473-479.
6. Pufulete M, Al-Ghnaniem R, Leather AJ, Apple-by P, Gout S, Terry C, Emery PW, Sanders TA. Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology 2003; 124: 1240-1248.
7. Lim U, Flood A, Choi SW, Albanes D, Cross AJ, Schatzkin A, Sinha R, Katki HA, Cash B, Schoenfeld P, Stolzenberg-Solomon R. Genom-ic methylation of leukocyte DNA in relation to colorectal adenoma among asymptomatic women. Gastroenterology 2008; 134: 47-55.
8. Nan H, Giovannucci EL, Wu K, Selhub J, Paul L, Rosner B, Fuchs CS, Cho E. Pre-diagnostic leukocyte genomic DNA methylation and the risk of colorectal cancer in women. PLoS One 2013; 8: e59455.
9. Huang WY, Su LJ, Hayes RB, Moore LE, Katki HA, Berndt SI, Weissfeld JL, Yegnasubramani-an S, Purdue MP. Prospective study of genomic hypomethylation of leukocyte DNA and colorec-tal cancer risk. Cancer Epidemiol Biomarkers Prev 2012; 21: 2014-2021.
10. Tse MY, Ashbury JE, Zwingerman N, King WD, Taylor SA, Pang SC. A refned, rapid and reproducible high resolution melt (HRM)-based method suitable for quantifcation of global LINE-1 repetitive element methylation. BMC Res Notes 2011; 4: 565.
11. Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, Fiala E, Ehrlich M, Laird PW. Analysis of repetitive element DNA methylation by Me-thyLight. Nucleic Acids Res 2005; 33: 6823-6836.
12. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. A simple method for estimating global DNA methylation using bisulfte PCR of repetitive DNA elements. Nucleic Acids Res 2004; 32: e38.
13. Foley DL, Craig JM, Morley R, Olsson CA, Dwyer T, Smith K, Saffery R. Prospects for epigenetic epidemiology. Am J Epidemiol 2009; 169: 389-400.
14. Phokaew C, Kowudtitham S, Subbalekha K, Shuangshoti S, Mutirangura A. LINE-1 methyla-tion patterns of different loci in normal and cancerous cells. Nucleic Acids Res 2008; 36: 5704-5712.
15. Wu HC, Delgado-Cruzata L, Flom JD, Kappil M, Ferris JS, Liao Y, Santella RM, Terry MB. Global methylation profles in DNA from different blood cell types. Epigenetics 2011; 6: 76-85.
16. McKay JA, Xie L, Harris S, Wong YK, Ford D, Mathers JC. Blood as a surrogate marker for tissue-specifc DNA methylation and changes due to folate depletion in post-partum female mice. Mol Nutr Food Res 2011; 55: 1026-1035.
17. Brennan K, Flanagan JM. Is there a link between genome-wide hypomethylation in blood and cancer risk? Cancer Prev Res 2012; 5: 1345-1357.
18. Friso S, Udali S, Guarini P, Pellegrini C, Pattini P, Moruzzi S, Girelli D, Pizzolo F, Martinelli N, Corrocher R, Olivieri O, Choi SW. Global DNA hypomethylation in peripheral blood mononu-clear cells as a biomarker of cancer risk. Cancer Epidemiol Biomarkers Prev 2013; 22: 348-355.
19. Marsit C, Christensen B. Blood-derived DNA methylation markers of cancer risk. Edited by Karpf AR. Epigenetic alterations in oncogenesis. New York: Springer Science+Business Media 2013; pp: 233-252.
20. Woo HD, Kim J. Global DNA hypomethylation in peripheral blood leukocytes as a biomarker for cancer risk: a meta-analysis. PLoS One 2012; 7: e34615.